Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice
Kathryn M. Shinnick, Elizabeth A. Eklund, Thomas J. McGarry
Kathryn M. Shinnick, Elizabeth A. Eklund, Thomas J. McGarry
View: Text | PDF
Research Article Hematology

Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice

  • Text
  • PDF
Abstract

HSCs maintain the circulating blood cell population. Defects in the orderly pattern of hematopoietic cell division and differentiation can lead to leukemia, myeloproliferative disorders, or marrow failure; however, the factors that control this pattern are incompletely understood. Geminin is an unstable regulatory protein that regulates the extent of DNA replication and is thought to coordinate cell division with cell differentiation. Here, we set out to determine the function of Geminin in hematopoiesis by deleting the Geminin gene (Gmnn) from mouse bone marrow cells. This severely perturbed the pattern of blood cell production in all 3 hematopoietic lineages (erythrocyte, megakaryocyte, and leukocyte). Red cell production was virtually abolished, while megakaryocyte production was greatly enhanced. Leukocyte production transiently decreased and then recovered. Stem and progenitor cell numbers were preserved, and Gmnn–/– HSCs successfully reconstituted hematopoiesis in irradiated mice. CD34+Gmnn–/– leukocyte precursors displayed DNA overreplication and formed extremely small granulocyte and monocyte colonies in methylcellulose. While cultured Gmnn–/– megakaryocyte-erythrocyte precursors did not form erythroid colonies, they did form greater than normal numbers of megakaryocyte colonies. Gmnn–/– megakaryocytes and erythroblasts had normal DNA content. These data led us to postulate that Geminin regulates the relative production of erythrocytes and megakaryocytes from megakaryocyte-erythrocyte precursors by a replication-independent mechanism.

Authors

Kathryn M. Shinnick, Elizabeth A. Eklund, Thomas J. McGarry

×

Figure 3

Defective stem and progenitor cell proliferation in GmnnΔ/Δ mice.

Options: View larger image (or click on image) Download as PowerPoint
Defective stem and progenitor cell proliferation in GmnnΔ/Δ mice.
   
(A...
(A) Typical stem cell flow cytometry profiles from pIpC-treated Mx1-Cre/Gemfl/fl mice (GmnnΔ/Δ) and pIpC-treated control littermates (control). (B) Quantification of stem cell populations. (C) Typical appearance of myeloid colonies grown from control and GmnnΔ/Δ marrow cells. Original magnification, ×200. (D and E) Number of erythroid and myeloid colonies (D) or megakaryocyte colonies (E) grown from control or GmnnΔ/Δ marrow cells. (F) Control or GmnnΔ/Δ MEPs were plated for erythroid colonies. Left, photographs of colony plates; right, number of colonies produced. Scale bar is 5 mm. (G) Control or GemΔ/Δ MEPs were plated for megakaryocyte colonies. Left, photographs of colony plates (megakaryocyte colonies are circled); right, number of colonies produced. Scale bar is 0.5 mm. For box-and-whisker plots, horizontal bar indicates the median, box indicates 25th to 75th percentiles, and whiskers indicate extremes. P values calculated from Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts